French Pharmaceuticals & Biotech Potentially Undervalued Companies

Vetoquinol

Market Cap: €892.2m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Euroapi

Market Cap: €227.2m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

Virbac

Market Cap: €2.5b

Manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Cellectis

Market Cap: €93.9m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Sanofi

Market Cap: €109.7b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Boiron

Market Cap: €408.0m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Eurofins Scientific

Market Cap: €8.9b

Provides various analytical testing and laboratory services worldwide.

Valneva

Market Cap: €450.5m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Ipsen

Market Cap: €7.8b

Operates as a biopharmaceutical company worldwide.

Valbiotis

Market Cap: €15.8m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Theranexus Société Anonyme

Market Cap: €3.1m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

OSE Immunotherapeutics

Market Cap: €118.8m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Sanofi

Market Cap: €109.7b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Aelis Farma

Market Cap: €16.8m

A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.

Oncodesign Precision Medicine Société anonyme

Market Cap: €8.4m

A biopharmaceutical company, engages in the precision medicine business.

MedinCell

Market Cap: €424.5m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Genfit

Market Cap: €148.6m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

MaaT Pharma

Market Cap: €82.2m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Innate Pharma

Market Cap: €142.8m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.